Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling

Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling

Eudebeiolide B is a eudesmane-type sesquiterpenoid compound isolated from <i>Salvia plebeia</i> R. Br., and little is known about its biological activity. In this study, we investigated the effects of eudebeiolide B on osteoblast differentiation, receptor activator nuclear factor-κB liga...

Full description

Bibliographic Details
Main Authors:	Mi-Hwa Kim, Hyung-Jin Lim, Seon Gyeong Bak, Eun-Jae Park, Hyun-Jae Jang, Seung Woong Lee, Soyoung Lee, Kang Min Lee, Sun Hee Cheong, Seung-Jae Lee, Mun-Chual Rho
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Pharmaceuticals
Subjects:	eudebeiolide B osteoporosis RANKL OVX mouse model calcium signal
Online Access:	https://www.mdpi.com/1424-8247/13/12/468

Similar Items

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
by: Jiarui Li, et al.
Published: (2022-11-01)

Anti-Osteoporotic Effects of <i>n-trans</i>-Hibiscusamide and Its Derivative Alleviate Ovariectomy-Induced Bone Loss in Mice by Regulating RANKL-Induced Signaling
by: Hyung Jin Lim, et al.
Published: (2021-11-01)

Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss
by: Sang-Yong Han, et al.
Published: (2021-12-01)

Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis
by: Wang Y, et al.
Published: (2019-09-01)

Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
by: Hui Liu, et al.
Published: (2021-03-01)

Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells
by: Seongtae Jeong, et al.
Published: (2020-08-01)

Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss
by: Xiaochen Sun, et al.
Published: (2020-03-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01)

Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
by: Feng-Jen Tseng, et al.
Published: (2015-07-01)

Corrigendum: Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
by: Jiachao Guo, et al.
Published: (2018-01-01)

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
by: Mohannad Ashtar, et al.
Published: (2020-04-01)

Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
by: Qiang Xu, et al.
Published: (2021-06-01)

Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption
by: Chenguang Niu, et al.
Published: (2017-09-01)

Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis
by: Ye Xiaoshuang, et al.
Published: (2022-08-01)

RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice
by: Mizuho Kittaka, et al.
Published: (2020-06-01)

Role of Mast-Cell-Derived RANKL in Ovariectomy-Induced Bone Loss in Mice
by: Verena Fischer, et al.
Published: (2023-05-01)

Identification of anti-osteoclastogenic compounds from Cleistocalyx operculatus flower buds and their effects on RANKL-induced osteoclastogenesis
by: Phuong Thao Tran, et al.
Published: (2019-09-01)

Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
by: Min Ma, et al.
Published: (2022-04-01)

The Effects of Aronia melanocarpa ‘Viking’ Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling
by: Mithun Ghosh, et al.
Published: (2018-03-01)

The Molecular Mechanisms Study of Engeletin Suppresses RANKL-Induced Osteoclastogenesis and Inhibits Ovariectomized Murine Model Bone Loss
by: Feng M, et al.
Published: (2023-05-01)

Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
by: Gang Wang, et al.
Published: (2022-01-01)

Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
by: Guoju Hong, et al.
Published: (2020-03-01)

Pan-histone deacetylase inhibitor vorinostat suppresses osteoclastic bone resorption through modulation of RANKL-evoked signaling and ameliorates ovariectomy-induced bone loss
by: Xiaole Peng, et al.
Published: (2024-03-01)

The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors
by: Věra Hedvičáková, et al.
Published: (2021-03-01)

Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling
by: Yoon-Hee Cheon, et al.
Published: (2020-09-01)

(−)-Epicatechin 3-O-β-d-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways
by: Hung-Bo Hsiao, et al.
Published: (2017-05-01)

Scopolin Prevents Adipocyte Differentiation in 3T3-L1 Preadipocytes and Weight Gain in an Ovariectomy-Induced Obese Mouse Model
by: Eunkuk Park, et al.
Published: (2020-11-01)

Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis
by: Minsun Kim, et al.
Published: (2020-02-01)

Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss
by: Weiduo Hou, et al.
Published: (2022-10-01)

A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5
by: Zhi Xin, et al.
Published: (2018-01-01)

3-Hydroxyolean-12-en-27-oic Acids Inhibit RANKL-Induced Osteoclastogenesis in Vitro and Inflammation-Induced Bone Loss in Vivo
by: Wonyoung Seo, et al.
Published: (2020-07-01)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
by: Dahu Qi, et al.
Published: (2021-01-01)

Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5
by: Zhi Xin, et al.
Published: (2021-03-01)

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
by: Eun-Jung Kim, et al.
Published: (2018-10-01)

Corydalis Saxicola Bunting Total Alkaloids Attenuate Walker 256-Induced Bone Pain and Osteoclastogenesis by Suppressing RANKL-Induced NF-κB and c-Fos/NFATc1 Pathways in Rats
by: Linjie Ju, et al.
Published: (2021-01-01)

Nox4 Promotes RANKL-Induced Autophagy and Osteoclastogenesis via Activating ROS/PERK/eIF-2α/ATF4 Pathway
by: Jing Sun, et al.
Published: (2021-09-01)

Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.
by: Seung-Youp Lee, et al.
Published: (2013-01-01)

Hexane Fraction of Turbo brunneus Inhibits Intermediates of RANK-RANKL Signaling Pathway and Prevent Ovariectomy Induced Bone Loss
by: Sachin Chaugule, et al.
Published: (2019-09-01)

<i>Eleutherococcus sessiliflorus</i> Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss
by: Sang-Yong Han, et al.
Published: (2021-03-01)

Niloticin inhibits osteoclastogenesis by blocking RANKL–RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways
by: Huanhuan Xu, et al.
Published: (2022-05-01)